Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aeterna Zentaris Inc

Current price
1.95 USD 0 USD (0.00%)
Last closed 2.7 CAD
Sector Healthcare
Industry Biotechnology
Exchange TO
Capitalization 13 097 512 CAD
Yield for 12 month -25.62 %
21.11.2021 - 28.11.2021

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is Macrilen (macimorelin), an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications; and AEZS-150, a delayed clearance parathyroid hormonefusion polypeptide that is in preclinical trail for the treatment of hypoparathyroidism in adults. Aeterna Zentaris Inc. has a license agreement with University of Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercialization of the treatment for neuromyelitis optica spectrum disorder; and for pre-clinical development towards the potential treatment of Parkinson's disease. It also has a license agreement with Consilient Health Ltd. and NK MEDITECH Ltd. for the development and commercialization of macimorelin in the Republic of Korea; a distribution and commercialization agreement with Er-Kim Pharmaceuticals Bulgaria EOOD for the commercialization of macimorelin for the diagnosis of growth hormone deficiency in children and adults in Turkey and some non-European Union Balkan countries; as well as The University of Sheffield, the United Kingdom for the research, development, manufacture, and commercialization of parathyroid hormone fusion polypeptides for the treatment of primary hypoparathyroidism. Aeterna Zentaris Inc. was incorporated in 1990 and is headquartered in Summerville, South Carolina. Address: 315 Sigma Drive, Summerville, SC, United States, 29486

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

5.52 CAD

P/E ratio

Dividend Yield

Current Year

+6 211 050 CAD

Last Year

+7 787 977 CAD

Current Quarter

+167 082 CAD

Last Quarter

+4 143 CAD

Current Year

+5 904 502 CAD

Last Year

+7 571 184 CAD

Current Quarter

+91 136 CAD

Last Quarter

-11 047 CAD

Key Figures AEZS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -17 973 660 CAD
Operating Margin TTM -5285.95 %
PE Ratio
Return On Assets TTM -24.19 %
PEG Ratio
Return On Equity TTM -61.34 %
Wall Street Target Price 5.52 CAD
Revenue TTM 4 493 415 CAD
Book Value 3.74 CAD
Revenue Per Share TTM 0.93 CAD
Dividend Share
Quarterly Revenue Growth YOY -95.1 %
Dividend Yield
Gross Profit TTM 5 164 730 CAD
Earnings Share -4.69 CAD
Diluted Eps TTM -4.69 CAD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics AEZS

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AEZS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date 11.08.1999
Forward Annual Dividend Yield
Last Split Factor 1:25
Payout Ratio
Last Split Date 21.07.2022
Dividend Date 02.01.2007

Stock Valuation AEZS

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.2001
Price Sales TTM 3.012
Enterprise Value EBITDA 1.8292
Price Book MRQ 0.5439

Financials AEZS

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AEZS

For 52 weeks

1.91 CAD 4.48 CAD
50 Day MA 2.63 CAD
Shares Short Prior Month 369
200 Day MA 2.93 CAD
Short Ratio 0.52
Shares Short 1 363
Short Percent 0.03 %

Dynamics of changes in the value of assets




414.58 USD Microsoft Corporation +0.12 (+0.03%)
Detailed analytics

ETF funds



208.70 CHF iShares MDAX UCITS ETF (DE) -11.84 (-4.92%)
Detailed analytics



2169.94 USD Gold -5.94 (-0.27%)
Detailed analytics